Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05608863

He-move-philia, Lifestyle Intervention for Patients With Hemophilia

Conditions: Hemophilia

Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 30
Sponsor: Radboud University Medical Center

Location: Netherlands

Summary

The main objectives are reduction of body weight, BMI and abdominal circumference. Secondary objectives are reduction of bleeds and units coagulation factor concentrate used, blood-pressure, cholesterol spectrum, glucose and improvement of physical activity and dietary habits. one group of patients will receive a combined lifestyle intervention program with individual sessions and group sessions lasting for 2 years, the other group of patients will receive individual sessions only and will be given the same information as given in the group sessions, but on paper.

Eligibility Criteria

Inclusion criteriaDiagnosed with hemophilia A, B, FVII deficiency, fibrinogen deficiency, von Willebrand Disease or other bleeding disorder preferably requiring coagulation products for prophylaxis or on demand in case of bleeding≥ 18 years of ageBMI ≥ 30 kg/m2Motivated to change their lifestyleBeing able to speak, read and understand the Dutch languageExclusion criteriaHealth care insurance with CZ or ONVZ as these health insurances have no contract with Profitt Lifestylecoaching.A contraindication or inability for physical activity as judged by the treating hemophilia physicianParticipation in another research trialUnable to understand the written informationUnable to sign the informed consentUnwilling to randomize to the combined or individual intervention group

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05608863). StuddyBuddy aggregates publicly available trial information.